Literature DB >> 8280777

Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.

J D Morrow1, T A Minton, K F Badr, L J Roberts.   

Abstract

F2-isoprostanes are prostaglandin (PG)F2-like compounds that are produced in vivo as non-enzymatic products of free radical catalyzed peroxidation of arachidonic acid. One F2-isoprostane whose formation should be favored is 8-epi-PGF2 alpha. 8-Epi-PGF2 alpha has been shown to exert potent bioactivity but proof that it is formed in vivo is lacking. Evidence is now presented suggesting that 8-epi-PGF2 alpha is, in fact, formed in vivo by demonstrating that an endogenous F2-isoprostane with a retention time on capillary GC identical with that of 8-epi-PGF2 alpha co-chromatographs through four high resolving HPLC purification procedures with authentic radiolabelled 8-epi-PGF2 alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8280777     DOI: 10.1016/0005-2760(94)90128-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction.

Authors:  Margarete Dulce Bagatini; Caroline Curry Martins; Vanessa Battisti; Diogo Gasparetto; Cintia Saydelles da Rosa; Roselia Maria Spanevello; Mushtaq Ahmed; Roberta Schmatz; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

2.  Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Authors:  D Praticò; L Iuliano; A Mauriello; L Spagnoli; J A Lawson; J Rokach; J Maclouf; F Violi; G A FitzGerald
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Human biochemistry of the isoprostane pathway.

Authors:  Ginger L Milne; Huiyong Yin; Jason D Morrow
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

4.  Mass spectrometric analysis of four regioisomers of F2-isoprostanes formed by free radical oxidation of arachidonic acid.

Authors:  R J Waugh; R C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  1996-05       Impact factor: 3.109

5.  Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.

Authors:  B M Kromer; J R Tippins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Isoprostanes.

Authors:  L Jackson Roberts; Ginger L Milne
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

7.  Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.

Authors:  P Patrignani; G Santini; M R Panara; M G Sciulli; A Greco; M T Rotondo; M di Giamberardino; J Maclouf; G Ciabattoni; C Patrono
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.

Authors:  M Nonaka-Sarukawa; K Yamamoto; H Aoki; H Takano; T Katsuki; U Ikeda; K Shimada
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

Review 9.  Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?

Authors:  Harold J Ting; Fadi T Khasawneh
Journal:  J Biomed Sci       Date:  2010-04-06       Impact factor: 8.410

10.  Regulation of thromboxane receptor signaling at multiple levels by oxidative stress-induced stabilization, relocation and enhanced responsiveness.

Authors:  Stephen K Ball; Mark C Field; John R Tippins
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.